Add 2 More Reports For 20% off

Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Global Ablation Technology Market Outlook

The global ablation technology market size attained a value of 6.05 billion in 2023. The market is expected to grow at a CAGR of 9.8% between 2024 and 2032, reaching almost 14.0 billion by 2032.

Ablation Technology: Introduction

Ablation technology is used in ablation therapy which is a minimally invasive tissue to destroy (ablate) an abnormal tissue present in any condition. The abnormal tissue can be destroyed through various techniques, including heat (radiofrequency), cold (cryoablation), chemicals, or lasers. It is done via a probe that is inserted through the skin, energy beams, or flexible tubes (catheters) inserted through an artery. It is mostly guided with the help of imaging techniques.

Ablation technologies find wide application in multiple domains ranging from surgery to radiation therapies. It causes less pain and allows a shorter recovery span as well as same day discharge in patients.

Global Ablation Technology Market Analysis

The worldwide prevalence of atrial fibrillation has approximately increased by 20%, affecting 0.51%  of the worldwide population. As medications do not always work to reduce the symptoms in many patients, the cardiac practitioners have diverted towards cardiac ablation for the treatment. This is one of the major drivers for ablation technology market demand.

Consequently, there has been active clinical research to bring new advances to the field. For instance, the Heart Rhythm Society announced the efficacy of pulsed field ablation, an alternative to conventional thermal treatment. This is a non-thermal ablation technology that utilizes electrical pulses to cause electroporation and induce cardiac cell death. In addition, in May 2024, Abbott’s TactiFlex™ Ablation Catheter, got approved by the FDA. This device can lead to safer and less time-consuming procedures. Hence, we can anticipate market growth in the ablation technology in the upcoming years.

Emerging technologies like microwave ablation (MWA), cryoablation, radiofrequency ablation (RFA) is also applied in oncological treatments. MWA and cryoablation are gradually growing as a stable alternative to surgical resection for non-small lung cancers, as MWA can control tumour progression while cryoablation extends a patient's survival span. The minimal invasiveness and low risk procedures indicate that the ablation technology market value is set to grow in the forecast period.

Global Ablation Technology Market Segmentation

Market Breakup by Technology

  • Radiofrequency Devices
  • Laser/Light Ablation
  • Ultrasound Devices
  • Cryoablation Devices
  • Other Devices

Market Breakup by Applications

  • Cancer Treatment
  • Cardiovascular Disease Treatment
  • Ophthalmologic Treatment
  • Gynaecological Treatment
  • Urological Treatment
  • Cosmetic Surgery
  • Others

Market Breakup by End User

  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Ablation Technology Market Overview

The North America, especially the United States, has dominated the ablation technology market share in the historical period. The presence of healthcare industry pioneers has played a significant role in driving efficient technical advances for the patients. Currently, major industry leaders like Johnson and Johnson, Medtronic and Boston Scientific Corporation are waiting for their respective pulsed field ablation catheters to be approved by the FDA. Boston Scientific Corporation’s first-generation pulse field ablation device “Farapulse” has already been approved by the EU in 2021. It will fetch FDA’s approval by 2024 tentatively. Similarly, Medtronic’s “Pulse Select” and Johnson & Johnson’s “Varipulse” are in queue as well.

The ablation technology market growth will be swift in the Asia Pacific region owing to the emphasis on the development of a medical technology driven infrastructure. With the availability of affordable resources, it has been welcoming plenty of foreign investments as well. In addition, the geriatric population will be a significant aspect of market growth. It may lead to a boost in the number of surgical procedures where ablation techniques may be applied. Hence, the market will grow in the forecast period.

Global Ablation Technology Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

  • Abbott
  • AngioDynamics, Inc. 
  • AtriCure, Inc.  
  • Boston Scientific Corporation 
  • BTG plc  
  • Conmed Corporation  
  • Johnson & Johnson 
  • Medtronic PLC  
  • Olympus Corporation  
  • Smith & Nephew PLC 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Technology
  • Applications
  • End User
  • Region
Breakup by Technology
  • Radiofrequency Devices
  • Laser/Light Ablation
  • Ultrasound Devices
  • Cryoablation Devices
  • Other Devices
Breakup by Applications
  • Cancer Treatment
  • Cardiovascular Disease Treatment
  • Ophthalmologic Treatment
  • Gynecological Treatment
  • Urological Treatment
  • Cosmetic Surgery
  • Others
Breakup by End User
  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Abbott
  • AngioDynamics, Inc.
  • AtriCure, Inc.
  • Boston Scientific Corporation
  • BTG plc
  • Conmed Corporation
  • Johnson & Johnson
  • Medtronic PLC
  • Olympus Corporation
  • Smith & Nephew PLC

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

The market attained a value of about USD 6.05 billion in 2023, driven by the preference of treating diseases like atrial fibrillation and cancer with ablation therapy.

The market is anticipated to grow at a CAGR of 9.8% during the forecast period of 2024-2032, likely to reach a market value of USD by 14.0 billion by 2032.

With the incidence of chronic illnesses, the preference for minimally invasive procedures that are efficient and have a shorter recovery span has grown, hence, the market demand for ablation technology has increased.

Several first-generation pulse field ablation devices like “Farapulse” by Boston Scientific Corporation, “Pulse Select” by Medtronic and “Varipulse” by Johnson & Johnson are the upcoming devices waiting for FDA approval. Microwave ablation (MWA), cryoablation, radiofrequency ablation (RFA) is among the emerging technologies applied in oncological treatments as well.

It include radiofrequency devices, laser/light ablation, ultrasound devices, and cryoablation devices, among other devices.

Ablation technology finds wide application in cancer, cardiovascular disease, ophthalmologic, gynaecological, urological treatment, and cosmetic surgery, among others.

End users include hospitals and clinics and ambulatory surgical centers, among others.

The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.

Key players involved in the market are Abbott, AngioDynamics, Inc., AtriCure, Inc., Boston Scientific Corporation, BTG plc, Conmed Corporation, Johnson & Johnson, Medtronic PLC, Olympus Corporation, and Smith & Nephew PLC.

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,499

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,699

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,599

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,599

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63-287-899-028, +63-967-048-3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63-287-899-028, +63-967-048-3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124